TABLE 3.
Subjects receiving AG-702 or control vaccine from whom immunogenicity data were obtained
| AG-702 or peptide dose (μg) | No. of subjects whose HSV serostatus was:
|
|
|---|---|---|
| Negative | HSV-2 positive and HSV-1 negative or positive | |
| 10 | 5 | 5 |
| 100 | 5 | 16 |
| 250 | 3 | 16 |
| Peptide (4) | 3 | 3 |
| Total | 16 | 40 |